Table 2.
Association of risk factors with time to lesion healing in patients with American cutaneous leishmaniasis treated with antimony*
| Risk factor | Crude hazard ratio (95% CI) | P | Multivariate hazard ratio† (95% CI) | P |
|---|---|---|---|---|
| Demographics | ||||
| Female | 0.84 (0.55–1.28) | 0.43 | – | – |
| Age per 10 years | 1.04 (0.86–1.20) | 0.87 | – | – |
| Clinical data | ||||
| Classic ulceration | 4.50 (1.65–12.30) | < 0.001 | 5.33 (1.67–16.99) | 0.005 |
| LST area per 100 mm2 | 1.24 (1.08–1.42) | 0.003 | 1.16 (1.14–1.33) | 0.03 |
| One lesion only | 1.11 (0.82–1.51) | 0.51 | – | – |
| Lesion area per 100 mm2 | 1.00 (0.95–1.05) | 0.99 | – | – |
| Helminth co-infection | 0.42 (0.24–0.74) | 0.006 | 0.43 (0.24–0.77) | 0.004 |
| Cytokines | ||||
| IFN-γ per 1,000 pg/mL‡ | 1.25 (1.10–1.42) | < 0.001 | ||
| TNF-α per 1,000 pg/mL‡ | 1.86 (1.16–2.97) | 0.01 |
CI = confidence interval; LST = Leishmania skin test; IFN-γ = interferon-γ; TNF-α = tumor necrosis factor-α.
Multivariate Cox proportional hazard models adjusted for ulceration, LST area, and helminth co-infection.
n = 46 persons with cytokine data.